HEALTHCARE RESOURCE UTILIZATION AND COST BURDEN OF FACIAL ANGIOFIBROMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: A REAL-WORLD CLAIMS DATABASE ANALYSIS IN THE UNITED STATES

被引：0
|
作者：
Hebert, A. A. [1 ]
Paydar, C. [2 ]
Das, A. K. [2 ]
Boggarapu, S. [3 ]
Beresford, E. [3 ]
机构：
[1] UT Hlth McGovern Med Sch, Houston, TX USA
[2] Partnership Hlth Analyt Res PHAR LLC, Beverly Hills, CA USA
[3] Nobelpharma Amer LLC, Bethesda, MD USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE407
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns, adherence, costs, and healthcare resource utilization associated with Waldenstrom macroglobulinemia in the United States.
    Yang, Keri
    Castillo, Jorge J.
    Ratiu, Anna
    Delinger, Rachel
    Zimmerman, Todd
    Tang, Boxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] Tamsulosin dispensation patterns in the United States: a real-world, longitudinal, population claims database analysis
    Kava, Bruce R.
    Verbeek, Anna E.
    Wruck, Jan M.
    Gittelman, Marc
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (04) : 329 - +
  • [23] Healthcare resource utilization and economic burden of multiple sclerosis in Chinese patients: results from a real-world survey
    Sun, Chenhan
    Jia, Yusheng
    Li, Hainan
    Qiao, Xuanqi
    Tang, Mi
    Geng, Meiyan
    Jones, Eddie
    Pike, James
    Unsworth, Mia
    Hu, Min
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
    Caroline Amand
    Sabine Tong
    Alexia Kieffer
    Moe H. Kyaw
    BMC Health Services Research, 18
  • [25] Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
    Amand, Caroline
    Tong, Sabine
    Kieffer, Alexia
    Kyaw, Moe H.
    BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [26] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Mease, Philip
    Young, Pamela
    Gruben, David
    Fallon, Lara
    Germino, Rebecca
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [27] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Mease, Philip J.
    Young, Pamela
    Gruben, David
    Fallon, Lara
    Germino, Rebecca
    Kavanaugh, Arthur
    ADVANCES IN THERAPY, 2022, 39 (06) : 2932 - 2945
  • [28] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Philip J. Mease
    Pamela Young
    David Gruben
    Lara Fallon
    Rebecca Germino
    Arthur Kavanaugh
    Advances in Therapy, 2022, 39 : 2932 - 2945
  • [29] EARLY REAL-WORLD EXPERIENCE OF TOFACITINIB FOR PSORIATIC ARTHRITIS: DATA FROM A UNITED STATES HEALTHCARE CLAIMS DATABASE
    Mease, P. J.
    Young, P.
    Gruben, D. C.
    Fallon, L.
    Germino, R.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1286 - 1287
  • [30] Healthcare burden associated with atrial flutter: Analysis of a nationally representative, commercial claims database in the United States
    Deshmukh, Abhishek
    Iglesias, Maximiliano
    Khanna, Rahul
    Beaulieu, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 559 - 560
12345